论文部分内容阅读
目的:系统地研究在脑梗塞的治疗中应用丹红注射液联合依达拉奉疗法的实际价值。方法:选取东莞市黄江医院2015年7月至2016年3月收治的120例脑梗塞患者,结合临床随机表法将其平均地列入观察组与对照组,对照组使用血栓通注射液进行常规治疗,观察组则应用丹红注射液联合依达拉奉进行治疗,对比两组患者神经功能缺损评分、日常生活能力评分以及治疗有效率。结果:治疗后,两组神经功能缺损评分和日常生活能力评分比较,差异具有统计学意义(P<0.05);观察组的治疗有效率是95.0%,对照组是81.7%,组间比较,差异具有统计学意义(P<0.05)。结论:在脑梗塞的治疗中,丹红注射液联合依达拉奉疗法能够有效地改善患者的神经功能和日常生活能力,进而可以显著地提高治疗有效率。
Objective: To systematically investigate the practical value of Danhong injection combined with edaravone in the treatment of cerebral infarction. Methods: A total of 120 patients with cerebral infarction admitted from July 2015 to March 2016 in Huangjiang Hospital of Dongguan City were enrolled in the observation group and the control group according to the randomized clinical trial. The control group was treated with Xueshuantong injection The patients in the observation group were treated with Danhong injection combined with edaravone. The neurological deficit score, daily living ability score and treatment efficiency were compared between two groups. Results: After treatment, the scores of neurological deficit scores and daily living ability scores of two groups were statistically significant (P <0.05). The effective rate of treatment in observation group was 95.0% and that in control group was 81.7% Statistically significant (P <0.05). Conclusion: Danhong injection combined with edaravone can effectively improve the neurological function and daily living ability of patients in the treatment of cerebral infarction, which can significantly improve the treatment efficiency.